Clinical Trials Arena

Women’s health clinical trials: breaking down barriers through decentralisation

Patient recruitment is one of the most challenging aspects of running clinical trials. Certain socioeconomic factors, such as the disproportionate…

Bristol Myers Squibb’s Mavacamten reduces surgical procedures among HCM patients

On April 2, Dr. Milind Desai and colleagues from the Cleveland Clinic Heart Vascular & Thoracic Institute presented their findings…

Roundtable: the future of AI in clinical research

Artificial Intelligence (AI) is quickly weaving itself into the fabric of our lives across all industries. The life sciences have…

Innovation Fund Denmark: attracting investment in clinical trials

Innovation Fund Denmark (IFD) is a public grant agency that part funds entrepreneurs, students and companies to make new products…

Telling the story: art’s potential to boost trial diversity

The matter of trial diversity has become a prominent and much talked about topic in clinical research circles. After decades…

Trial endpoints: is it time to get selective on surrogates?

The use of surrogate endpoints in clinical research is becoming increasingly common as a way to accelerate getting drugs to…

How ketamine trials are providing a blueprint for suicidal ideation research

There are currently no good treatments for people thinking about ending their lives. The World Health Organization recently estimated that,…

Impressive early results for Vertex’s potentially curative stem cell diabetes therapy

On Monday, Vertex Pharmaceuticals announced that the first Type 1 diabetes (T1D) patient to be dosed in the Phase I/II…

Remote communities of healthcare professionals are enabling DCTs

The healthcare industry’s spur to innovate in response to the Covid-19 pandemic has been both impressive and necessary. Perhaps one…

pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end

pHOXBIO aims to start a UK-based Phase I trial of its preventive Covid-19 nasal spray before the end of the…